RTHawk vs EchoNext

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

RTHawk

by HeartVista Cardiac Package

EchoNext

by Pathway Labs

AI Verdict

RTHawk and EchoNext are adjacent competitors in cardiology AI, both FDA-cleared, but focus on different diagnostic modalities. RTHawk enhances cardiac MRI acquisition and analysis, providing real-time imaging and preliminary functional measures. EchoNext, conversely, analyzes standard ECGs to detect hidden structural heart disease, acting as a screening tool to identify patients who may need further investigation like an echocardiogram.

Choose RTHawk if…

Choose RTHawk if your cardiology practice or hospital needs to significantly streamline and automate cardiac MRI acquisition and analysis. This tool is ideal for improving patient throughput and diagnostic efficiency with its one-click automation, real-time imaging capabilities, and AI-assisted optimization of cardiac exams.

View RTHawk →

Choose EchoNext if…

Choose EchoNext if your clinical setting requires an accessible and non-invasive method for early detection of hidden structural heart disease from standard ECGs. This tool is particularly well-suited for broad screening in various settings, from major hospitals to community practices, to identify patients at risk for conditions like heart failure, valve disease, and pulmonary hypertension, potentially leading to earlier intervention.

View EchoNext →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	RTHawk	EchoNext
Pricing	Contact for pricing	Starts at $600/month
Deployment	On-premise (integrated with existing MRI scanners)	Available through the OpenEvidence clinical decision support platform.
BAA Available	Unknown	Yes AI-estimated
FDA Status	1 AI-estimated	Yes AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

RTHawk

RTHawk emphasizes 'one-click automation' and 'real-time imaging' for cardiac MRI acquisition, suggesting a highly streamlined and user-friendly experience for technicians. EchoNext, while non-invasive and using standard ECGs, is deployed through a separate platform, which might introduce an additional layer of complexity for users compared to RTHawk's direct integration with MRI scanners.

Clinical Value

Tie

Both tools offer significant clinical value by addressing critical needs in cardiology. RTHawk enhances the efficiency and quality of cardiac MRI, improving diagnostic capabilities for structural and functional heart conditions. EchoNext provides early detection of hidden structural heart disease from standard ECGs, potentially leading to earlier interventions and improved patient outcomes. Both are FDA-cleared, indicating validated clinical utility.

Pricing & Value

EchoNext

EchoNext provides transparent tiered pricing starting at $600/month, including details on implementation fees and discounts, which allows potential customers to estimate costs upfront. RTHawk's pricing is 'contact for pricing,' which offers less transparency and makes it harder to assess immediate value without direct engagement.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness. RTHawk integrates with existing MRI scanners and is FDA-cleared, indicating suitability for hospital radiology departments. EchoNext is available through the OpenEvidence clinical decision support platform, targets a broad range of practices, and offers custom plans for larger institutions, suggesting robust scalability and integration capabilities for diverse healthcare settings. Both also confirm HIPAA compliance and BAA availability.

Innovation

RTHawk

RTHawk's 'one-click automation' and 'real-time, free-breathing' cardiac MRI acquisition, along with an 'artifact detection neural network' and AI-assisted inversion time optimization, represent significant innovation in complex imaging. While EchoNext's ability to detect hidden structural heart disease from ECGs is innovative, RTHawk's advancements in streamlining and enhancing a traditionally challenging imaging modality stand out more in terms of technological breakthrough.

Support & Docs

Tie

Neither product's provided information or readily available web searches offer specific details about their support services, documentation, or training programs. Without this information, it is not possible to definitively determine a winner in this dimension, leading to a tie.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	RTHawk	EchoNext
Name	RTHawk	EchoNext
Company	HeartVista Cardiac Package	Pathway Labs
Tagline	AI-Powered One-Click Cardiac MRI for Enhanced Diagnostics	How's your heart?
Categories	Cardiology AI, Radiology & Imaging AI	Cardiology AI, Clinical Decision Support & Reference, Lab & Diagnostics
Specialties	Cardiology, Radiology	Cardiology, Family Medicine, Hospital Medicine, Internal Medicine
Key Features	AI-assisted MRI acquisition software, One-Click Cardiac Package MRI software, Real-time, free-breathing, and breath-hold sequences for cardiac exams, Automates standard cardiac views, Artifact detection neural network, Optimizes inversion time with AI assistance, 4D flow measurement application, Provides preliminary measures of left ventricular function (ejection fraction, volumes, mass)	AI-powered ECG analysis, Detection of hidden structural heart disease, Identifies heart failure risk, Screens for valve disease, Detects pulmonary hypertension indicators, Utilizes standard 12-lead ECGs, FDA-cleared technology, Non-invasive diagnostic support

Videos

Demos, reviews, and walkthroughs featuring RTHawk and EchoNext.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows for cardiac evaluation?

RTHawk integrates with existing MRI scanners, offering a 'one-click' automation for cardiac MRI acquisition and real-time imaging, which can simplify the process for technologists and potentially increase throughput. EchoNext integrates with the OpenEvidence clinical decision support platform, allowing physicians to submit ECGs for AI-assisted analysis within a tool many already use, thereby streamlining the screening process for structural heart disease.

What is the accuracy and sensitivity of each tool in detecting cardiac conditions?

RTHawk provides AI-assisted MRI acquisition and advanced analysis, including preliminary measures of left ventricular function, with real-world data showing improved image quality and reduced scan times. EchoNext, trained on over 700,000 ECG-echocardiogram pairs, demonstrated higher accuracy (77%) in identifying structural heart problems from ECGs compared to cardiologists (64%) in a head-to-head comparison.

What is the learning curve for physicians and technicians using these tools?

RTHawk aims to simplify cardiac MRI operation to 'just a few clicks,' suggesting a reduced learning curve for technologists by automating complex tasks. EchoNext analyzes standard 12-lead ECGs, a routine test, and its integration with OpenEvidence may reduce the learning curve for physicians by presenting the AI's output within a familiar platform.

What kind of clinical impact can be expected from implementing these tools?

RTHawk can enable faster cardiac MRI exams, potentially reducing scan times significantly and making cardiac MRI more accessible for diagnosing conditions like cardiomyopathies and heart failure. EchoNext can detect hidden structural heart disease from ECGs, including heart failure, valve disease, and pulmonary hypertension, enabling earlier detection and potentially guiding earlier interventions.

Are there audit-trail features available to track the AI's contribution to diagnosis or image acquisition?

While the provided information for RTHawk highlights its real-time imaging and artifact detection, specific details about audit-trail features for tracking AI contributions to image acquisition or analysis are not explicitly mentioned. For EchoNext, the integration with a clinical decision support platform suggests that its output would be part of a documented clinical workflow, but explicit audit-trail features for the AI's analysis are not detailed.

How do these tools support multi-site rollout and standardization across a healthcare system?

RTHawk's on-premise deployment and integration with existing MRI scanners could facilitate multi-site rollout by leveraging current infrastructure, with a focus on standardizing cardiac MRI acquisition. EchoNext's availability through the OpenEvidence platform, which serves over 500,000 physicians nationwide, suggests a design for broad access and consistent application across various clinical settings, from major hospitals to community practices.